PhytoHealth Corporation (4108.TW)

TWD 14.35

(7.49%)

Total Assets Summary of PhytoHealth Corporation

  • PhytoHealth Corporation's latest annual total assets in 2023 was 2.35 Billion TWD , down -0.6% from previous year.
  • PhytoHealth Corporation's latest quarterly total assets in 2024 Q2 was 2.34 Billion TWD , down -1.25% from previous quarter.
  • PhytoHealth Corporation reported annual total assets of 2.36 Billion TWD in 2022, down -4.27% from previous year.
  • PhytoHealth Corporation reported annual total assets of 2.47 Billion TWD in 2021, up 36.5% from previous year.
  • PhytoHealth Corporation reported quarterly total assets of 2.34 Billion TWD for 2024 Q2, down -1.25% from previous quarter.
  • PhytoHealth Corporation reported quarterly total assets of 2.34 Billion TWD for 2023 Q3, down -1.71% from previous quarter.

Annual Total Assets Chart of PhytoHealth Corporation (2023 - 2009)

Historical Annual Total Assets of PhytoHealth Corporation (2023 - 2009)

Year Total Assets Total Assets Growth
2023 2.35 Billion TWD -0.6%
2022 2.36 Billion TWD -4.27%
2021 2.47 Billion TWD 36.5%
2020 1.8 Billion TWD -3.84%
2019 1.88 Billion TWD -9.01%
2018 2.06 Billion TWD -5.65%
2017 2.19 Billion TWD -9.6%
2016 2.42 Billion TWD 3.64%
2015 2.33 Billion TWD -6.0%
2014 2.48 Billion TWD -11.85%
2013 2.82 Billion TWD -2.06%
2012 2.88 Billion TWD 74.7%
2011 1.65 Billion TWD -13.45%
2010 1.9 Billion TWD -9.79%
2009 2.11 Billion TWD 0.0%

Peer Total Assets Comparison of PhytoHealth Corporation

Name Total Assets Total Assets Difference
Grape King Bio Ltd 15.51 Billion TWD 84.847%
Standard Chem & Pharm CO., LTD. 11.18 Billion TWD 78.992%
Maywufa Company Ltd. 2.83 Billion TWD 17.004%
ScinoPharm Taiwan, Ltd. 11.72 Billion TWD 79.947%
Lotus Pharmaceutical Co., Ltd. 32.99 Billion TWD 92.875%
LIWANLI Innovation Co., Ltd. 834.17 Million TWD -181.777%
YungShin Global Holding Corporation 11.51 Billion TWD 79.583%
SCI Pharmtech, Inc. 6.69 Billion TWD 64.869%
Formosa Laboratories, Inc. 13.63 Billion TWD 82.763%
PharmaEssentia Corporation 27.26 Billion TWD 91.38%
Bora Pharmaceuticals Co., LTD. 25.05 Billion TWD 90.617%